Literature DB >> 15203979

Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC.

G Ramadan1, S Konings, V P Kurup, C A Keever-Taylor.   

Abstract

BACKGROUND: Recent reports have described a new strategy for differentiation and maturation of monocyte (Mo)-derived DCs within only 48 h of in vitro culture (fast-DC). Here we assess the efficacy of the fast-DC to process and present different Aspergillus fumigatus and CMV Ag preparations to autologous T cells, compared with DCs generated in standard 7-day cultures (standard-DC).
METHODS: Adherent blood Mo were treated with GM-CSF and IL-4 (1 day for fast-DC, 5 days in the standard-DC) to generate immature DCs, and then were matured for either 1-2 days (fast-DC) or 2 days (standard-DC) with inflammatory cytokines. DCs were pulsed with A. fumigatus or CMV Ag preparation immediately prior to maturation, or infected after maturation with adeno-pp65. Mature DCs were then used to prime Ag-specific proliferative and cytotoxic T lymphocytes (CTL) responses.
RESULTS: Fast-DC were CD14- and expressed mature DC surface markers to the same degree as standard-DC, and maintained this phenotype after withdrawing cytokine from the cultures. Fast-DC and standard-DC were equally capable of inducing A. fumigatus and CMV-specific T-cell proliferation, as well as priming Ag-specific CTL activity. The Aspergillus- and CMV-specific CTL were of mixed CD3+/CD4+ and CD3+/CD8+ phenotype, and specifically killed autologous DC pulsed with A. fumigatus Ag and autologous CMV infected fibroblasts, respectively. DISCUSSION: Fast-DC are as effective as standard-DC in the generation of Ag-specific T-cell responses. Moreover, use of fast-DC not only reduces labor and supply cost, as well as workload and time, but also increases the number of DCs derived from adherent Mo, which may facilitate the use of DCs in clinical trials of cellular immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15203979     DOI: 10.1080/14653240410006040

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  9 in total

1.  Generation of Th1 T cell responses directed to a HLA Class II restricted epitope from the Aspergillus f16 allergen.

Authors:  G Ramadan; B Davies; V P Kurup; C A Keever-Taylor
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

2.  Generation of functional monocyte-derived fast dendritic cells suitable for clinical application in the absence of interleukin-6.

Authors:  Gamal Ramadan
Journal:  Cytotechnology       Date:  2011-07-16       Impact factor: 2.058

3.  Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen.

Authors:  G Ramadan; B Davies; V P Kurup; C A Keever-Taylor
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

Review 4.  Brief in vitro IL-12 conditioning of CD8 + T Cells for anticancer adoptive T cell therapy.

Authors:  Mohamed Labib Salem; Samar Salman; Ibrahim O Barnawi
Journal:  Cancer Immunol Immunother       Date:  2021-05-08       Impact factor: 6.968

5.  Challenges and prospects of adoptive immunotherapy in prevention and treatment of opportunistic mycoses in hematologic transplant recipients.

Authors:  Lars Tramsen; Stanislaw Schmidt; Frauke Roeger; Ulrike Koehl; Thomas Lehrnbecher
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

Review 6.  Plant-derived polysaccharides activate dendritic cell-based anti-cancer immunity.

Authors:  Siambi Kikete; Li Luo; Beitian Jia; Li Wang; Gregory Ondieki; Yuhong Bian
Journal:  Cytotechnology       Date:  2018-03-19       Impact factor: 2.058

7.  Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses.

Authors:  F Zhu; G Ramadan; B Davies; D A Margolis; C A Keever-Taylor
Journal:  Clin Exp Immunol       Date:  2007-11-14       Impact factor: 4.330

8.  Induction of A. fumigatus-specific CD4-positive T cells in patients recovering from invasive aspergillosis.

Authors:  Hetty Jolink; Renate S Hagedoorn; Ellen L Lagendijk; Jan W Drijfhout; Jaap T van Dissel; J H Frederik Falkenburg; Mirjam H M Heemskerk
Journal:  Haematologica       Date:  2014-04-18       Impact factor: 9.941

9.  CD8(+) T cells implicated in the pathogenesis of allergic fungal rhinosinusitis.

Authors:  Harshita Pant; Peta Macardle
Journal:  Allergy Rhinol (Providence)       Date:  2014-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.